Irvine Scientific says it will build a media R&D lab at its Orange County site

By Staff Reporter

- Last updated on GMT

iStock/JVisentin
iStock/JVisentin

Related tags: Dna, Cell culture

Irvine Scientific has announced plans for an R&D centre at its site in Irvine, California citing increasing biopharma industry demand for cell culture and media regents.  

In addition to the R&D centre, the new building will house departments currently located at its headquarters in neighbouring Santa Ana. Irvine said the reorganisation will enable it to “expand other capabilities, such as media customization​.”

COO Tim Mullane said the new space will allow “us to expand our space and staff dedicated to advancing cell culture technology important​.”

The expansion plan follows a number of product launches.

In July​ last year, Irvine launched a medium for neuronal cells for pharmaceutical firms developing regenerative medicines and drugs for central nervous system disorders.

A month later it released BalanCD HEK293, a system designed to increase viral vector and recombinant protein production yields.

The technology comprises a chemically defined media that supports the growth of human embryonic kidney (HEK293) cells, which can be used for the production of proteins and gene therapy vectors.

It is designed to be used to support growth of the cell lines before and after transfection – in other systems media but be changed after genetic material has been inserted.

In January​, Irvine rolled out a chemically-defined, animal component-free medium for T cell culture.

Last month​, Irvine launched a serum-free, xeno-free basal medium designed for the expansion of hematopoietic progenitors for customers working with HSPCs.

Related news

Related products

show more

Small-Scale Cell Culture Perfusion Process

Small-Scale Cell Culture Perfusion Process

Eppendorf for Bioprocess – Solutions that grow with you | 29-Mar-2019 | Application Note

Perfusion cell culture processes promise advantages for industrial bioprocessing, like saving space, increasing volumetric productivity, achieving more...

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Single-Step Influenza and Dengue Virus Purification

Single-Step Influenza and Dengue Virus Purification

Bio-Rad Laboratories | 08-Oct-2018 | Application Note

CHT XT is the newest addition to the CHT family of media. It has been designed for superior physical robustness to ensure it can be used repeatedly over...

Related suppliers

Follow us

Products

View more

Webinars